Healthcare & Life Sciences
Modus Therapeutics
Sweden
series-b
series-b
Stage
1
Investors
About
Modus Therapeutics is a biotechnology company developing treatments aimed at improving outcomes in acute respiratory distress syndrome (ARDS) and other critical care conditions by targeting inflammation and vascular leakage.
Explore Modus Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.